IonMedicine has used as its primary work instrument metabolomics –a technology that allows for the identification and quantification of metabolites produced by the biological systems– and, through the analysis of post genomics, can express individual’s biochemical phenotype, which is groundbreaking in the way that the approach for health grievances is done.
The study of genomics (genes), transcriptomics (mRNA), proteomics (proteins) and metabolomics composes a new technology known as OMICS. Metabolomics differs from the others for it globally evaluates a system’s metabolites (cell, tissue or organism).
In this way, it may not only be used for the comprehension of normal physiology, but especially in the better understanding of the metabolic alterations involved in the etiology of illnesses, which allows for metabolomics to become a fundamental tool in medical diagnosis and prognosis.
Company Details
- Employees
- 16
- Founded
- 2018
- Address
- Rua Apiacás, 247, 1o Andar,brazil
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- ionmedicine.com.br
- Keywords
- Medicina Personalizada, Metabolômica, Metabolomics, Medicina Diagnóstica, Diagnosis, Metabolismo, Agricultura de Precisão, Pecuária de Precisão, Ômicas, Biológicos.
- HQ
- São Paulo, SP
Ionmedicine Questions
Ionmedicine's website is ionmedicine.com.br
Ionmedicine's LinkedIn profile is https://br.linkedin.com/company/ionmedicine
Ionmedicine has
16 employees.
View email and phone details for 16
employees at Ionmedicine.
Ionmedicine's industry is
Biotechnology Research
Ionmedicine's top competitors are
Ionnutri,
Ideelab,
Medmep Excelência Em Medicina Personalizada,
Bioprocess Improvement,
Laboratório Cristália,
Salú,
Senne Liquor Diagnóstico,
Biosab Leveduras,
Fundação Butantan,
Crop Labs.
Ionmedicine's categories are Biotechnology Research
Ionmedicine's founding year is 2018
